22 results
424B3
CHRO
Chromocell Therapeutics Corp.
15 May 24
Prospectus supplement
4:21pm
General and administrative expenses
Research and development
Professional fees
Total operating expenses
NET LOSS FROM OPERATIONS
OTHER (EXPENSE) INCOME … limits.
Research and Development
We incur research and development costs during the process of researching and developing our technologies and future
424B3
CHRO
Chromocell Therapeutics Corp.
15 May 24
Prospectus supplement
4:15pm
General and administrative expenses
Research and development
Professional fees
Total operating expenses
NET LOSS FROM OPERATIONS
OTHER (EXPENSE) INCOME … limits.
Research and Development
We incur research and development costs during the process of researching and developing our technologies and future
10-Q
2024 Q1
EX-10.3
CHRO
Chromocell Therapeutics Corp.
15 May 24
Quarterly report
4:06pm
, technologies, therapies or services in any way related to the therapeutic mechanisms of action that are being evaluated in the Company’s active research … and development efforts at that time. It is agreed that ownership of no more than one percent (1%) of the outstanding voting stock of a publicly traded
10-Q
2024 Q1
CHRO
Chromocell Therapeutics Corp.
15 May 24
Quarterly report
4:06pm
EXPENSES
General and administrative expenses
Research and development
Professional fees
Total operating expenses
NET LOSS FROM OPERATIONS
OTHER (EXPENSE … cash equivalents.
As of March 31, 2024, the Company had deposits in excess of federally insured limits.
Research and Development
We incur research
424B3
CHRO
Chromocell Therapeutics Corp.
16 Apr 24
Prospectus supplement
5:49pm
and local levels, as well as outside the United States, extensively regulate, among other things, the research, development, testing, manufacture … our ability to raise capital, maintain our research and development efforts, expand our business or continue our operations. A decline in the value
424B3
4xj0ld
16 Apr 24
Prospectus supplement
5:45pm
10-K
qnnnc5 syye
16 Apr 24
Annual report
4:48pm
424B4
2yu hnby7ojwzq
20 Feb 24
Prospectus supplement with pricing info
5:30pm
424B4
d2de5e1hxqle31
20 Feb 24
Prospectus supplement with pricing info
5:28pm